Osteoporosis

>

Latest News

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
FDA Adds Boxed Warning to Denosumab (Prolia) for Severe Hypocalcemia

January 19th 2024

On January 19, 2024, the FDA announced the addition of a Boxed Warning to the labeling of denosumab (Prolia), citing evidence of an increased risk of severe hypocalcemia in patients with chronic kidney disease.

DPP-4i Treatment Significantly Reduces Osteoporosis Risk in Patients with Type 2 Diabetes
DPP-4i Treatment Significantly Reduces Osteoporosis Risk in Patients with Type 2 Diabetes

December 19th 2023

Advancing Personalized Web-Based Decision Reports for Enhanced Patient Care
Advancing Personalized Web-Based Decision Reports for Enhanced Patient Care

July 9th 2023

Miriam Bredella, MD | Credit: Harvard Medical School
Study Links Weight Loss Surgery in Adolescents, Young Adults to Weakened Bones

June 13th 2023

Carolyn Crandall, MD, MS, MACP | Credit: UCLA Health
Study Finds FRAX Score Could Be Missing the Mark for Women in the US

May 23rd 2023

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.